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Background: Dilated cardiomyopathy (DCM) is often associated with conduction system diseases. However, the underlying molecular mechanisms 
remain unclear. We have previously identified the D117N mutation in the Z-band Alternatively Spliced PDZ motif (ZASP1), in a DCM patient with 
conduction disturbances, while the ZASP1-K136M was found in a DCM subject with no conduction defects. This study sought to elucidate the 
role of ZASP1-D117N in regulating the cardiac sodium channel (hNav1.5), which is critically involved in conduction system diseases. Methods: 
Patch-clamp techniques were used to measure INa in either HEK293 cells stably expressing hNav1.5 or neonatal rat cardiomyocytes (NRCM), both 
transiently transfected with WT or mutant ZASP1. Pull-down assay and immunohistochemistry (IHC) analysis were employed to study the interaction 
and localization between hNav1.5, WT and mutant ZASP and other cytoskeletal proteins.
Results: Macroscopic INa were significantly decreased in cells expressing D117N compared to WT and K136M (WT, -252.0 ± 24.5 pA/pF, n = 20; 
K136M, -259.7 ± 37.1 pA/pF, n = 17; D117N, -182.2 ± 18.5 pA/pF, p<0.05). ZASP1-D117N, not K136M, rightward shifted steady-state activation 
(Vh: WT, -44.3 ± 1.6 mV, n = 23; K136M, -44.0 ± 2.5 mV, n = 17; D117N, -36.9 ± 1.6 mV, n = 18, p<0.05) and steady-state inactivation (Vh: 
WT, -100.3 ± 1.4 mV, n = 16; K136M, -100.9 ± 2.6, n = 17; D117N, -92.9 ± 1.4 mV, n = 19, p<0.005). Same INa reduction occurred in NRCM 
expressing D117N, but not ZASP1-WT. Furthermore, pull-down and IHC experiments demonstrated that both WT and D117N ZASP1 co-localized with 
the complex including hNav1.5, Telethonin and ACTN2, although NRCM expressing ZASP1-D117N demonstrate less organized Z-line. Treatment using 
ML-7, a cytoskeleton disruption agent, normalized INa parameters, rescuing hNav1.5 function.
Conclusions: ZASP1-D117N decreases hNav1.5 function via a hNav1.5/Teletholnin/ZASP1/ACTN2 complex, and might account for conduction 
disturbances associated with DCM. Our study suggests that disrupted cytoarchitectural proteins are the primary cause of cardiomyopathies, and may 
predispose to secondary ion channel dysfunction and cardiac arrhythmias.
